T-cells genetically altered to seek and kill cancer don’t do much good if the tumor’s density stops it from contacting the offending tissue, a challenge Roger Williams Medical Center researchers have evidence they’ve overcome in a recent clinical trial of TriSalus Life Sciences’ pressure-enabled, drug-delivery catheter. Dr. Steven Katz, director of the Office of Therapeutic
Already a Subscriber? Log in
To Continue Reading This Article
Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.Learn More and Become a Subscriber
- Critical RI business news and analysis updated daily.
- 1 year of print (26 issues).
- Unlimited access to all subscriber only content on our website, on any device.
- Free email alerts.
- Annual Book of Lists Print Edition.
- All special issues produced during subscription term.
Click Here to purchase a paywall bypass link for this article
PBN Branded Content
Seifert Systems Invests in Energy Efficiency to Strengthen Operations
For manufacturers, energy is more than just another operating expense. It plays a critical role…
Learn More
